Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release - Wikidata - awgldk - TriplyDB

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release

http://www.wikidata.org/entity/Q35981563

about

Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression The tumor microenvironment in esophageal cancer Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment Macrophage-tumor cell interactions regulate the function of nitric oxide Endogenously produced nitric oxide mitigates sensitivity of melanoma cells to cisplatin Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells Dual inhibition of the vascular endothelial growth factor pathway: a phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Effects of BRAF mutations and BRAF inhibition on immune responses to melanoma The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization.L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.CD11b deficiency suppresses intestinal tumor growth by reducing myeloid cell recruitment.Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumors.Contributions of neutrophils to the adaptive immune response in autoimmune disease.Myeloid derived suppressor cells: Targets for therapy.Targeting the therapeutic effects of exercise on redox-sensitive mechanisms in the vascular endothelium during tumor progression Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.The metastasis-promoting roles of tumor-associated immune cells Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.Tumor microenvironment and myeloid-derived suppressor cells.Modulation of immunity by antiangiogenic molecules in cancer.Immune-suppressive properties of the tumor microenvironment.Myeloid-derived suppressor cells in cancer: recent progress and prospects.Tumor-altered dendritic cell function: implications for anti-tumor immunity.Dendritic cell defects in the colorectal cancer Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.Tumour, Oxidative Stress and Host T Cell Response: Cementing the Dominance.Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.Galectin-3 contributes to cisplatin-induced myeloid derived suppressor cells (MDSCs) recruitment in Lewis lung cancer-bearing mice.The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.Nitric oxide: what's new to NO?Immunology Comes Full Circle in Melanoma While Specific Immunity Is Unleashed to Eliminate Metastatic Disease, Inflammatory Products of Innate Immunity Promote Resistance.Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.

P2860

Q27027064-F19B94CF-D2EE-4B8C-9370-42726D5B2F5D Q28076760-95B52330-07CA-425D-B5C0-A17A6F703386 Q28077074-70FFEF6C-62B9-4FC9-B66D-727D124F9C85 Q28080262-83FE17DB-A990-4424-B620-0019AADBDBBD Q28241308-3C455C27-D75B-4FE0-BD01-AB7D8D939049 Q28384490-7409D94B-F09F-4E3D-901B-5D92F08BD360 Q28392262-738E19D1-247E-4DE7-A135-8D48EA066FAB Q28393356-3C26DA6F-B99A-499A-8E4F-CD73E8288321 Q28553169-AF22A923-B8B6-4754-A5BE-C9665AA5C8FC Q33414769-EF45A916-BE76-4C4F-8FD8-072C424AEC28 Q34101036-C841DD8D-170E-4C10-A441-2625C327D50E Q34646279-EE98C68F-7F37-44E9-B535-C3E2CEF74B18 Q34846497-18CF8BD1-CD93-45F4-8773-A004F8A66708 Q35311873-71C43C9C-659F-4639-9E0B-B233D255D139 Q36035570-4EA51D9D-D990-4069-B14C-60128F038858 Q36242193-44D68D7C-548D-42DB-9707-4243A89C42D2 Q36275124-BD7C0B2F-0BC8-45C5-97D7-645A1236B947 Q36619606-0B9880E7-91DA-4AD3-9406-4882D2B8023A Q36751862-86C44AE1-0921-410C-BB94-C447B2B362CB Q36845851-0F9653C9-9F9C-439B-9446-AC8DEDC54DD7 Q36951553-522C34C4-D58E-4025-B004-1F6DDC27AA74 Q36967364-699FA04B-D162-4DAB-BF71-556EEC634B11 Q36972016-C1498E01-7853-4B5F-8D1E-706D16E650B5 Q37692764-B81BEA70-39D2-4C99-AD22-2D8497E3C606 Q37695537-38C089AE-CDAD-4982-BB02-0E8E5FD36C45 Q38067642-D88F2E99-0137-454E-BE57-35DB1EB228B9 Q38074154-08B0664F-7E21-4C14-A485-0E7E337D9CF9 Q38105970-A2D21DB7-2F34-4ABF-B666-1408733EF0B5 Q38116711-22517D2E-CBE4-4228-82FD-09B231DFD8B3 Q38123166-8631194C-1CFE-4914-8B11-2A6D9BBD71F9 Q38284706-A02E336B-45BD-4124-B36B-399FED0B21D9 Q38398117-55F32522-F9E5-49BC-95F4-9F72426F9035 Q38569178-89404EFC-6823-4B3E-9464-F6345049AE66 Q38939956-C37C60EF-3908-4249-8868-B7BE5F3EFDDD Q39016689-3EC2ED71-F35E-4F8E-80B1-517CB848B180 Q39034031-82A4BBEA-70AE-4287-A443-8FF965906E60 Q39038560-6FCB31F2-832A-4C50-8A26-E120B0471609 Q39536215-C0E385C4-A15F-48FE-9CDA-99ABED96D8DE Q40468319-414D8DED-6C7E-48BD-A545-48126B69E266 Q41514095-1793FDCD-D391-4B11-B9AC-49F520422EF8

P2860

Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release

http://www.wikidata.org/entity/Q35981563

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Tumor-expressed inducible nitr ...... othelial growth factor release

@ast

Tumor-expressed inducible nitr ...... othelial growth factor release

@en

type

label

Tumor-expressed inducible nitr ...... othelial growth factor release

@ast

Tumor-expressed inducible nitr ...... othelial growth factor release

@en

prefLabel

Tumor-expressed inducible nitr ...... othelial growth factor release

@ast

Tumor-expressed inducible nitr ...... othelial growth factor release

@en

P1433

Q35981563-66C12233-837F-4AEB-B6C0-CA74C38D0458

P1476

Q35981563-F9EA87BD-7CC4-41D7-8833-655B0224B0E2

P2093

Q35981563-0C5CD21B-CFE2-4952-8FBD-3719681AF091

Q35981563-1412587A-AA34-4BE8-9888-B797A8EA4C7F

Q35981563-1689E16D-205D-470A-85DB-B48DB38F4209

Q35981563-343B9A0D-776A-40D8-8F3C-073F3A996BFC

Q35981563-6FECAD17-5F6C-4FAF-BA1B-2458E91E05EB

Q35981563-7B1CFD69-8C89-4891-BB9A-51BB7496FFF8

Q35981563-7CCE0AED-A74A-4F82-B087-E13B27ECA976

Q35981563-84197203-0326-4D8A-BDBE-26B24CBE1655

Q35981563-9CCEB350-E43C-46E3-A0E2-948987E53BE0

Q35981563-CAB9892A-D4C4-4993-9581-8956770577BD

P2860

Q35981563-1EC14DBD-A57F-4D9A-83A2-1471C98635AA

Q35981563-396A9610-07FF-4C4D-BD12-AC67005457FA

Q35981563-3F65BBBB-FDCA-4526-B5E5-09E45B4EC45E

Q35981563-3FD5B703-32D0-4E45-9B83-ACD88C6299FE

Q35981563-44702FC3-7CEE-4ADF-85E2-BFD4E789A6BE

Q35981563-4D736F0E-EA02-4426-B697-D287B6060DAC

Q35981563-56A4CF9E-E6FD-4CA2-9A60-238E1C832AD8

Q35981563-63CB2A78-1C49-4002-B60F-A8AF0DB63FAF

Q35981563-65383057-73A6-4245-97DF-5466C6B21BDF

Q35981563-6A8A100A-DF02-485B-9CB9-AE97F195E595

P304

Q35981563-E100E684-A359-4743-A94E-56043BB24595

P31

Q35981563-3A3FCC36-6128-4548-AAE7-B98C558B6A31

P356

Q35981563-B0DB62D8-0D71-4660-AFC2-5F014BDE6C4C

P407

Q35981563-E12BD43D-D18A-43C3-AFE7-CFF03A5013BC

P433

Q35981563-A0952A71-6363-481A-9F5D-9861D25C4DB9

P478

Q35981563-EA64178C-50FA-44B5-B1A4-3C93D9899033

P577

Q35981563-5C5A4D61-55FC-4181-8831-B237DF4167EA

P5875

Q35981563-4E778DA4-D46D-45EB-A625-BB52DE3E1175

P698

Q35981563-29E21BFB-7D7C-4DA0-922B-2C7D97C8D787

P921

Q35981563-91567652-F9EA-40EA-AF74-9EC9924B8E81

P932

Q35981563-A6176340-6AB3-4584-833A-FD9782BF7A16

P356

JIMMUNOL.1103553

P1433

Journal of Immunology

P1476

Tumor-expressed inducible nitr ...... othelial growth factor release

@en

P2093

Amelia Clark

http://www.w3.org/2001/XMLSchema#string

Andrew G Sikora

http://www.w3.org/2001/XMLSchema#string

David Cannan

http://www.w3.org/2001/XMLSchema#string

Esther Lopez-Rivera

http://www.w3.org/2001/XMLSchema#string

Falguni Parikh

http://www.w3.org/2001/XMLSchema#string

Ge Ma

http://www.w3.org/2001/XMLSchema#string

Marcel Ramacher

http://www.w3.org/2001/XMLSchema#string

Masashi Kato

http://www.w3.org/2001/XMLSchema#string

Padmini Jayaraman

http://www.w3.org/2001/XMLSchema#string

Shu-Hsia Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Myeloid-derived suppressor cells: linking inflammation and cancer

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Myeloid-derived suppressor cells as regulators of the immune system

Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

Modulators of arginine metabolism support cancer immunosurveillance.

Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy

Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

P304

5365-5376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1103553

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

188

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224824869

http://www.w3.org/2001/XMLSchema#string

P698

22529296

http://www.w3.org/2001/XMLSchema#string

P921

P932

3358566

http://www.w3.org/2001/XMLSchema#string